1. Home
  2. CABR vs BNGO Comparison

CABR vs BNGO Comparison

Compare CABR & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caring Brands Inc.

CABR

Caring Brands Inc.

HOLD

Current Price

$1.40

Market Cap

13.1M

ML Signal

HOLD

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.74

Market Cap

12.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CABR
BNGO
Founded
2020
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
13.1M
12.5M
IPO Year
2025
2018

Fundamental Metrics

Financial Performance
Metric
CABR
BNGO
Price
$1.40
$1.74
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
38.8K
2.2M
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
94.50
EPS
N/A
N/A
Revenue
$4,215.00
$12,000,735.00
Revenue This Year
N/A
$14.99
Revenue Next Year
N/A
$34.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.26
52 Week Low
$0.71
$1.00
52 Week High
$1.84
$2.23

Technical Indicators

Market Signals
Indicator
CABR
BNGO
Relative Strength Index (RSI) 56.79 83.19
Support Level $1.24 $1.10
Resistance Level $1.58 N/A
Average True Range (ATR) 0.12 0.17
MACD 0.02 0.06
Stochastic Oscillator 66.04 55.56

Price Performance

Historical Comparison
CABR
BNGO

About CABR Caring Brands Inc.

Caring Brands Inc is a wellness consumer products company. It offers several over-the-counter (OTC) and cosmetic consumer products. Its product pipeline includes a diverse products, such as hair loss treatments, eczema and psoriasis treatments, vitiligo solutions, a jellyfish sting protective suncare line, and women's sexual wellness products, catering to diverse health and wellness needs. It operates in a single segment.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Share on Social Networks: